Linzess
New agreement gives AstraZeneca full responsibility for Linzess in China
September 18, 2019Research and Development AstraZeneca, IBS-C, Linzess
AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals in China for Linzess (linaclotide), a first-in-class new treatment for patients …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
